Tizanidine vs. Methocarbamol: Differences, Risks, Overdose, and Safer Use

Tizanidine and methocarbamol are both widely prescribed muscle relaxers. On paper, they seem interchangeable. In reality, they behave very differently in the body.

That difference matters. For someone dealing with back pain or muscle spasms, choosing between these two medications can affect:

• Day-to-day functioning
• Sedation levels
• Blood pressure
• Risk of overdose
• Interaction with other substances

And in a treatment setting like Brooks Healing Center, it matters even more because both medications are often used in patients who may also be dealing with substance use, withdrawal, or central nervous system sensitivity.

This guide breaks down tizanidine and methocarbamol in a way that actually helps you understand what you’re taking and what risks come with it.

Table 1. Quick Comparison: Tizanidine vs Methocarbamol

Category	Tizanidine	Methocarbamol
Drug class	Alpha-2 adrenergic agonist	Centrally acting muscle relaxant
Primary use	Neurological spasticity	Acute musculoskeletal pain
Sedation level	High	Moderate
Blood pressure effects	Can lower BP significantly	Minimal impact
Liver impact	Requires monitoring	Lower risk overall
Abuse potential	Low to moderate (indirect)	Low
Overdose risk	Higher with CNS depression	Lower but still present

Tizanidine is stronger neurologically. Methocarbamol is more general and milder.

Table 2. Tizanidine Pill Identification Guide

Strength	Common Color	Shape	Imprint / Marking	Scored	Notes
2 mg	White to off-white	Round	“A 594” or “T2” (varies by manufacturer)	Yes (usually bisected or quartered)	Most commonly prescribed starting dose
4 mg	White to light yellow	Round	“A 595” or “T4”	Yes (often quad-scored)	Often designed to be split into smaller doses
6 mg (capsule)	Blue/white or purple/white	Capsule	Manufacturer-specific code	No	Extended-release capsule form

What to Look for With Tizanidine

• Most tablets are round and white
• Frequently scored deeply, sometimes in a cross pattern (can break into 2–4 pieces)
• Often has simple alphanumeric imprints rather than brand names

Table 3. Methocarbamol Pill Identification Guide

Strength	Common Color	Shape	Imprint / Marking	Scored	Notes
500 mg	Orange	Round	“54 737” or similar numeric codes	Yes	One of the most recognizable versions
500 mg	White	Round	“M 500” or manufacturer code	Yes	Alternate generic version
750 mg	White	Capsule-shaped (oblong)	“M 750” or “West-ward 292”	Yes	Most commonly dispensed higher dose
750 mg	White	Oblong	Numeric imprint varies	Yes	Larger tablet, harder to confuse with smaller doses

What to Look for With Methocarbamol

• Orange round tablets are very common at 500 mg
• White oblong tablets are typical for 750 mg
• Usually larger pills than tizanidine
• Imprints are often numeric or “M” followed by strength

How Each Medication Works in the Body

Tizanidine

Tizanidine works directly on the central nervous system. It is an alpha-2 adrenergic agonist, meaning it reduces nerve signaling in the brain and spinal cord. That’s why it’s often used for:

• Multiple sclerosis
• Spinal cord injury
• Severe spasticity

It essentially “turns down” nerve activity, which relaxes muscles but also affects alertness, blood pressure, and heart rate. Because of this mechanism, it’s considered more potent in terms of neurological impact.

Methocarbamol

Methocarbamol works differently. Its exact mechanism isn’t fully understood, but it primarily depresses central nervous system activity without directly targeting nerve pathways.

It is typically used for:

• Acute back pain
• Muscle injuries
• Strains and sprains

It’s more of a broad, supportive muscle relaxer rather than a targeted neurological agent.

Which One Is Stronger?

This is where most blogs get it wrong.

There is no universal “stronger” muscle relaxer, and studies show no significant difference in overall effectiveness across many muscle relaxants.

But clinically:

• Tizanidine feels stronger because of sedation and CNS suppression
• Methocarbamol feels milder and more functional for daily use

That distinction matters more than the word “strong.”

Side Effects: Where the Real Differences Show Up

Table 4. Side Effect Comparison Table

Side Effect	Tizanidine	Methocarbamol
Drowsiness	Very common	Common
Dizziness	Common	Common
Low blood pressure	Significant risk	Rare
Dry mouth	Common	Less common
Nausea	Possible	Common
Liver effects	Possible, requires monitoring	Rare
Confusion	Possible	Less likely

Tizanidine is more likely to cause:

• Heavy sedation
• Low blood pressure (hypotension)
• Fatigue

Methocarbamol tends to cause:

• Mild sedation
• Dizziness
• Nausea

Tizanidine’s stronger sedative effect is well documented and is one of the main reasons clinicians use it cautiously.

Overdose Risk: What Actually Happens

This is where the Resurgence article only scratches the surface. Let’s go deeper.

Tizanidine Overdose

Tizanidine overdose affects multiple systems at once:

• Severe sedation or unconsciousness
• Low blood pressure
• Slow heart rate (bradycardia)
• Confusion or agitation
• Coma in severe cases

Because it impacts both the brain and cardiovascular system, tizanidine overdose can become dangerous quickly, especially when combined with:

• Alcohol
• Benzodiazepines
• Opioids

Methocarbamol Overdose

Methocarbamol overdose is generally less severe but still serious:

• Extreme drowsiness
• Nausea and confusion
• Respiratory depression (especially when combined)
• Seizures or coma in rare cases

Deaths are rare when taken alone, but risk increases significantly when combined with other depressants.

Table 5. Overdose Risk Comparison

Factor	Tizanidine	Methocarbamol
CNS depression	High	Moderate
Cardiovascular impact	Significant	Minimal
Risk when combined	Very high	High
Solo overdose severity	Moderate to severe	Mild to moderate

Bottom line:
Tizanidine carries higher systemic risk, especially due to blood pressure and heart effects.

Mixing These Medications: A Hidden Risk

Some people assume combining muscle relaxers will improve relief. It doesn’t.

Combining tizanidine and methocarbamol:

• Increases sedation
• Increases fall risk
• Raises overdose risk
• Does not improve effectiveness

This is especially important in recovery settings where patients may already be sensitive to CNS depressants.

Dependence, Misuse, and Real-World Risk

Neither medication is considered highly addictive in the traditional sense. But that doesn’t mean they are risk-free.

Tizanidine

• Can cause rebound symptoms if stopped abruptly
• Sedation can lead to misuse for sleep
• Often combined with other substances unintentionally

Methocarbamol

• Lower misuse potential
• Still contributes to CNS depression
• Risk increases in polydrug use

In treatment environments, the risk is rarely the medication alone. It’s the combination.

Which One Is Safer?

Table 6. General Safety Breakdown

Scenario	Better Option
Daytime function needed	Methocarbamol
Severe spasticity	Tizanidine
Risk of low blood pressure	Methocarbamol
Polysubstance risk	Methocarbamol
Sleep support needed	Tizanidine (with caution)

Methocarbamol is generally considered safer for everyday use because it is less sedating and has fewer systemic effects.

Tizanidine is more targeted and effective for neurological conditions but carries more risk.

Use in Detox and Recovery Settings

At facilities like Brooks Healing Center, muscle relaxers may be used during:

• Opioid withdrawal
• Alcohol withdrawal support
• General pain management

But the choice matters.

Why Methocarbamol Is Often Preferred

• Lower sedation risk
• Less impact on blood pressure
• Better for patients already fatigued

When Tizanidine May Be Used

• Severe muscle spasms
• Sleep disruption during withdrawal
• Controlled, monitored settings

The goal is always the same: Reduce discomfort without increasing risk.

The Bigger Risk: Combining with Other Substances

This is where most overdoses actually happen. Both medications become significantly more dangerous when combined with:

• Alcohol
• Benzodiazepines
• Opioids
• Sleep medications

These combinations stack CNS depression, leading to:

• Slowed breathing
• Loss of consciousness
• Increased overdose risk

This is one of the biggest concerns in real-world use.

Key Takeaways

• Tizanidine is more neurologically potent and more sedating
• Methocarbamol is milder and better tolerated for daily use
• Both carry overdose risk, especially when combined with other substances
• Tizanidine has higher cardiovascular risk (low blood pressure, heart rate changes)
• Methocarbamol is generally safer in recovery and outpatient settings

The difference between tizanidine and methocarbamol isn’t just about effectiveness. It’s about risk. One leans toward stronger neurological impact and higher systemic risk. The other leans toward safer, more functional daily use.

In a treatment setting, the difference can be the line between stabilization and setback.

Frequently Asked Questions About Methocarbamol and Tizanidine

Sources

1. American Academy of Family Physicians. (2008). Choosing a skeletal muscle relaxant. https://www.aafp.org/pubs/afp/issues/2008/0801/p365.html
2. Cashin, A. G., Folly, T., Bagg, M. K., Wewege, M. A., Jones, M. D., Ferraro, M. C., … & McAuley, J. H. (2021). Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: Systematic review and meta-analysis. BMJ, 374, n1446. https://pmc.ncbi.nlm.nih.gov/articles/PMC8262447/
3. DailyMed. (n.d.). Methocarbamol tablet prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42c0a177-7d62-4bcf-9fce-7dd484cda4d5
4. DailyMed. (n.d.). Tizanidine tablet prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72f25135-1333-4e52-83f5-7df7d90e68bb
5. Ghanavatian, S., & Derian, A. (2023). Tizanidine. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK519505/
6. LiverTox. (2017). Methocarbamol. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548286/
7. Oldfield, B. J., et al. (2024). Long-term use of muscle relaxant medications for chronic pain: A systematic review. JAMA Network Open, 7(9), e2433594. https://pmc.ncbi.nlm.nih.gov/articles/PMC11413720/
8. Sibrack, J., & Hammer, R. (2024). Methocarbamol. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK565868/
9. Spiller, H. A., Bosse, G. M., & Adamson, L. A. (2004). Retrospective review of tizanidine overdose. Journal of Toxicology: Clinical Toxicology, 42(5), 593–596. https://pubmed.ncbi.nlm.nih.gov/15462150/
10. U.S. Food and Drug Administration. (2003). Robaxin (methocarbamol tablets, USP) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf
11. U.S. Food and Drug Administration. (2024). Zanaflex (tizanidine hydrochloride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020397Orig1s029%2C021447Orig1s017lbl.pdf